Adverse Events Associated with Plateletpheresis: A Tertiary Care Hospital Experience in Southern India

Shanthi, B; Kumar, Vivek; Mahesh, K P Karun; Krishna, B. Murali

doi:10.7860/jcdr/2019/40415.12866

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, for the purpose of prevention of adverse events of citrate etiology, donors were supplemented with calcium salts (calcium lactate gluconate and calcium carbonate) before and during the procedure. In a similar study done in Southern India, a similar citrate related toxicity reactions (2.43%) were seen 20 . Citrate toxicity due to hypocalcemia may cause perioral paresthesia of the extremities, tremors, dizziness, chills, tetany and seizure.…”

Section: Discussionsupporting

confidence: 63%

Adverse events associated with donor plateletpheresis: A 10-year experience from Vojvodina, Serbia

2022

View full text Add to dashboard Cite

Background/Aim. Plateletpheresis is a medical procedure used for the collection of donor platelets with multiple benefits for patients who will receive apheresis platelets. The procedure takes one hour and is well tolerated by donors. Nevertheless, adverse events may occur during and after the plateletpheresis procedure. The aim was to present one centre experiences in order to determine the incidence and type of adverse events associated with donor plateletpheresis. Methods. A retrospective analysis of adverse events associated with donor plateletpheresis was conducted in the Blood Transfusion Institute of Vojvodina over the period from January 1, 2010 through December 31, 2019. Results. Out of 2073 platelet donors 94.84% were multiple blood donors, predominantly male (98.55%). Adverse events were identified during 180 (8.68%) platelet donations with no statistical significance in occurrence in the first time (10.28%) and repeat donors (8.59%). Mild local reactions related to venous access (42.22%) were the most common adverse events. Generalized symptoms exhibited 16.67% of donors, 26.11% exhibited symptoms related to apheresis - citrate reactions and 15% exhibited those related to other complications. During plateletpheresis occurred 95.55% adverse events and 4.45% after. Conclusion. Donor plateletpheresis is a generally safe procedure, well tolerated by donors. Understanding risk factors for possible occurrence of adverse events provide support for adoption of measures to prevent them.

show abstract

Section: Discussionsupporting

confidence: 63%